SEC Form 4/A · accession 0001209191-19-017155
Flexion Therapeutics Inc · FLXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Kerry Wentworth
Officer — Chief Regulatory Officer
Period of report
Oct 6, 2018
Accepted (ET)
Mar 5, 2019 · 8:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419600
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 6, 2018 | M | 3,400 | — | A | 15,878 | D | |
| Common StockF2 | Oct 8, 2018 | F | 1,002 | $18.60 | D | 14,876 | D | |
| Common Stock | holding | — | — | — | 6,000 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Unit AwardF1,F3 | — | Oct 6, 2018 | M | 3,400 | D | — | Oct 6, 2019 | Common Stock | 3,400 | 3,400 | D |
Explanation of responses
- F1Each restricted stock unit award represents a contingent right to receive one share of the Issuer's common stock.
- F2Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of the restricted stock unit award.
- F33,400 shares subject to the restricted stock unit award vested as of October 6, 2018 and the remaining 3,400 shares vest as of October 6, 2019.